ELDN icon

Eledon Pharmaceuticals
ELDN

Overview Fund Activity

48 hedge funds and large institutions have $70M invested in Eledon Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
+4
Holders Change %
+9.09%
% of All Funds
1.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
18
Reduced
9
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
KCM
1
Kingdon Capital Management
New York
$7.66M
2
AC
2
Ascend Capital
California
$1.13M
3
SCM
3
Sio Capital Management
New York
$930K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.17M
5
GOCM
5
Green Owl Capital Management
New York
$1.24M

Top Sellers

1
RG
1
Redmile Group
California
$0
2
AIC
2
AWM Investment Company
New York
$0
3
Deutsche Bank
3
Deutsche Bank
Germany
$510K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$0
5
PA
5
Perceptive Advisors
New York
$5.48M
Name Holding Trade Value Shares
Change 		Shares
Change %
AIC
51
AWM Investment Company
New York
– -$1.47M -617 Closed
Susquehanna International Group
52
Susquehanna International Group
Pennsylvania
– -$351K -147 Closed
DCM
53
Destrier Capital Management
New York
– -$248K -104 Closed
Bank of Montreal
54
Bank of Montreal
Ontario, Canada
– -$118K -49 Closed
1 2
3